Slide 1: Sitara Peroxide Limited Corporate Briefing Session by CEO & CFO
Sitara Peroxide Limited Corporate Briefing Session by CEO & CFO FOR THE YEAR ENDED JUNE 30, 2025 FEBRUARY 06, 2026
Slide 2: Presentation Outlines
Presentation Outlines Title & Overview Financial Highlights FY 2025 vs FY 2024 Financial Performance Overview Debt and Financing Update Operational Status Future Outlook & Risks Conclusion
Slide 3: Title & Overview
Title & Overview Sitara Peroxide Limited oAnnual Corporate Briefing – FY 2025 oPrepared from Audited Annual Report (June 30, 2025) Company Profile oPublic-listed entity on Pakistan Stock Exchange oPrincipal activity: Manufacturing & sale of Hydrogen Peroxide (H₂O₂) and related chemical products oR
Slide 4: Financial Highlights
Financial Highlights Description FY-2025 FY-2024 (Rs) (Rs) Sales - 14,900,700 Cost of Sales - (215,355,697) Gross Profit/(Loss) - (200,454,997) Loss before taxation & levies (311,354,016) (305,511,754) Loss for the year after tax provision (222,518,844) (169,350,221) Loss per share (Basic & Diluted)
Slide 5: Financial Performance Overview
Financial Performance Overview oLoss before taxation increased slightly to Rs 311.35 million including depreciation Rs.180.263 million oLoss after taxation increased to Rs 222.52 million in FY 2025 in comparison with loss after taxation Rs 169.350 million oLoss per share is Rs 4.04 in FY 2025 vs Rs
Slide 6: Debt and Financing Update
Debt and Financing Update oSettlement agreement with UBL Sukuk trustee extended upto Nov 2025 for full & final settlement Sukuk facility oPartial payments of Rs 81.5 million made out of internal resources oManagement committed to make company debt-free shortly and arranging fresh funding for BMR
Slide 7: Operational Status
Operational Status oOngoing repair & maintenance during shutdown is being made despite financial constraints oAdditional financing efforts are underway for BMR completion and restoring operations oImmediate need for FESCO electric connection to resume prime load operations
Slide 8: Future Outlook & Risks
Future Outlook & Risks oManagement focused on securing funding to complete BMR oBMR will enhance capacity, efficiency, and competitiveness oExport opportunities targeted in international market to ensure enhance capacity utilization
Slide 9: Conclusion
Conclusion oFY 2025 was a challenging year focused on restructuring and preparation for growth oManagement is confident for BMR implementation and return to profitable operations oCommitment to improving operational performance and shareholder value
Slide 10: Question / Answer Session
Sitara Peroxide Limited Question / Answer Session